Suresh Pullela 

Chief Quality Officer

Suresh Pullela joined Medera as Chief Quality Officer in January 2022.

Suresh has over 20 years of biotechnology and pharmaceutical industry experience across multiple therapeutic modalities (across early clinical to late stage/commercial companies). He has held roles in Quality Engineering/Validation, External Quality, and CMC Quality Technical Operations with the companies such as PAREXEL, Baxter BioScience (now Takeda), and Genentech/Roche.

Suresh most recently served as Senior Director of Quality Assurance at Harpoon Therapeutics, which includes early to mid-stage T cell engager therapy portfolio across multiple cancer indications. In addition, Suresh served as a consultant supporting FDA remediation activities. Before Harpoon, he spent 3 years at Ultragenyx where he was responsible for Quality oversight of Biologics programs spanning clinical and commercial stages of the development lifecycle.

Suresh holds a Bachelors in Engineering from Andhra University, India, and a Master of Science in Mechanical Engineering from North Carolina State University, Raleigh, NC.